Jay Salpekar
Clinical Neurophysiology · Washington, DCNPI 1679663942
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,275 of the $20,450 with a category attached, or 74.7%. 10 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 53.8% of the total. Reporting peaked in 2024 at $8,715 and has fallen 91.2% since, to $764 in 2025.
Across 56 payments — averaging $365.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$11K
- Eisai Inc.$7K
- Greenwich Biosciences, Inc.$653
- UCB, Inc.$503
- Ironshore Pharmaceuticals Inc.$246
- SK Life Science, Inc.$230
- plus $475 from 4 others
Across 4 payments — averaging $72,844 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$263K
- Lundbeck LLC$29K
What the payments were for
- Consulting fees$15,27575%
- Travel & lodging$1,0425%
- Food & beverage$4,13320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 19 | $11,011 |
| Eisai Inc. | 11 | $7,332 |
| Greenwich Biosciences, Inc. | 10 | $653 |
| UCB, Inc. | 5 | $503 |
| Ironshore Pharmaceuticals Inc. | 2 | $246 |
| SK Life Science, Inc. | 2 | $230 |
| Collegium Pharmaceutical, Inc. | 2 | $200 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $122 |
| Tris Pharma Inc | 2 | $93 |
| Pfizer | 1 | $60 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical neurophysiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 60 | $9,574 |
| Escitalopram Oxalate | 18 | $1,701 |
| Propranolol Hcl | 33 | $542 |
| Quetiapine Fumarate | 28 | $379 |
| Guanfacine Hcl ErGuanfacine Hcl | 13 | $274 |
| Sertraline Hcl | 19 | $235 |
| Lithium Carbonate | 11 | $217 |
| Benztropine Mesylate | 11 | $92 |
| Clonazepam | 15 | $64 |
| Citalopram HbrCitalopram Hydrobromide | 19 | $25 |
Paid to pharmacies, not to this prescriber.
Other clinical neurophysiology in Washington
- Perry RichardsonWashington$74K
- Adelaide RobbWashington$45K
- Sumanjit KaurWashington$4K
- Mark LinWashington$613
- Thanh NguyenWashington$569
- Jessica StevensWashington$415
- Robert LaurenoWashington$85
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.